NRAS and leukemia: Conversely, we note that some oncogene mutations can also confer drug resistance e.g. NRAS-mutant leukemia cells (Supplementary Fig. 10, n = 38 hits in Fig. 4a), consistent with prior reports (discussed in Supplementary Note 1).